Furthermore, the 3D organoid population treated with SM-3 showed a marked reduction in the levels of stem cell markers (CD44 and CD133) and stem cell transcription factors (SOX2 and OCT4) in lung cancer organoids (Fig. 9E, S3E, S4E). The gene discussed is POU5F1; the disease is lung carcinoma.